Clearside Biomedical, Inc. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3f199a97-b5a7-409a-8e2f-a7acffc39afe/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-34.4M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-046134 |
| FY 2023 | $-32.5M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-030126 |
| FY 2022 | $-32.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007732 |
| FY 2021 | $376.0k | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003468 |
| FY 2020 | $-18.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013027 |
| FY 2019 | $-30.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010810 |
| FY 2018 | $-82.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007887 |
| FY 2017 | $-59.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006055 |
| FY 2016 | $-25.9M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004643 |
| FY 2015 | $-17.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-004643 |
| FY 2014 | $-10.2M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-004643 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Clearside Biomedical, Inc. — all facts · Revenue · Operating Income